Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-44,300
Closed -$109K 2293
2025
Q1
$109K Hold
44,300
﹤0.01% 1651
2024
Q4
$139K Hold
44,300
﹤0.01% 1584
2024
Q3
$218K Hold
44,300
﹤0.01% 1543
2024
Q2
$195K Buy
44,300
+4,500
+11% +$21.1K ﹤0.01% 1568
2024
Q1
$268K Sell
39,800
-2,500
-6% -$19K ﹤0.01% 1476
2023
Q4
$315K Buy
42,300
+35,300
+504% +$301K ﹤0.01% 1445
2023
Q3
$71K Buy
+7,000
New +$149K ﹤0.01% 1761

Other funds holding SLRN

STRS Ohio's SLRN Position: Q2 2025 in Review

STRS Ohio sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 44,300 shares — an estimated $109K sold.

STRS Ohio first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $315K in Q4 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • STRS Ohio reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • STRS Ohio sold 44,300 ACELYRIN shares in Q2 2025, an estimated $109K.
  • STRS Ohio first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
  • STRS Ohio's ACELYRIN position peaked at $315K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.